Skip to content

Change in AR at other companies

LivaNova logo
LivaNovaLIVN
$14.67M+277%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$2.02M+339%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$2.96M+225%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$839K-25.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$4.36M-24.7%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$58K

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s change in AR?
Neuropace, Inc. (NPCE) reported change in AR of $108K in Q1 2026.
How has Neuropace, Inc.'s change in AR changed year-over-year?
Neuropace, Inc.'s change in AR decreased by 95.8% year-over-year, from $2.59M to $108K.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.